<p>|Recommendations|Level of evidence (evidence [refs.] reviewed)†|
|---|---|
|In adult patients with active PsA and diabetes who are both OSM- and biologic treatment–naive,| |
|1. Start an OSM other than MTX over a TNFi biologic (PICO 63a)|Very low (118, 119)|
|Conditional recommendation based on very-low-quality evidence; may consider starting a TNFi, if the patient has severe PsA§ or severe/active skin disease,¶ when diabetes is well controlled.| |